23AndMe, the popular genetic testing company, has filed for Chapter 11 bankruptcy with the U.S. Bankruptcy Court for the Eastern District of Missouri, and now, users are wondering what to do about ...

SAN FRANCISCO, March 21, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (ME), a leading human genetics company with a mission to help people access, understand, and benefit from the human genome, today ...

Valerie is a seasoned writer and editor who has spent her career creating content in the parenting and women's wellness spaces. Before joining Forbes Health, Valerie was the trending news editor at ...

Matthew Herper covers medical innovation — both its promise and its perils. 23andMe plans to give its customers the capacity to import their medical records, allowing what it calls “a 360-degree view ...

Experts urge 23andMe costumers to delete their data after genetic company files for bankruptcy. Even if 23andMe costumers delete their data, the company will still retain some of your genetic ...

San Francisco-based 23andMe, which sells at-home DNA testing kits, has filed for bankruptcy in the US and is looking for a new buyer — heightening concerns about the personal data of millions of ...

23andMe Trouble Sparks Calls for Users to Delete Their DNA Data: Here's How After 23andMe’s board of directors resigns, the president of encrypted messaging app Signal joins other security experts in ...

The company, which went public in 2021 with a $6 billion valuation, has never turned a profit and faced challenges including a data breach and a class-action lawsuit. 23andMe plans to sell ...

Concerns have been raised about how 23andMe could potentially handle customer information due to the company's uncertain future. The South San Francisco-based DNA and ancestry company is currently ...

23andMe, one of the first companies to provide direct-to-consumer genetic testing kits, has filed for bankruptcy. Since its founding in 2006, it has sold over 12 million DNA kits, with high-profile ...

The company, which went public in 2021 with a $6 billion valuation, has never turned a profit and faced challenges including a data breach and a class-action lawsuit. 23andMe plans to sell ...